Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Minsheng Health (301507) on March 26th, the main funds net bought 74,300 yuan.
Securities Star News: As of the market close on March 26, 2026, Minsheng Health (301507) closed at 13.7 yuan, down 1.15%. The turnover rate was 2.22%. Trading volume was 24.4k lots, and trading value was 33.735 million yuan.
Regarding the capital flow data for March 26, institutional main fund net inflows were 74.3 thousand yuan, accounting for 0.22% of the total trading value; brokerage funds net inflows were 2.3522 million yuan, accounting for 6.97% of the total trading value; retail funds net outflows were 2.4265 million yuan, accounting for 7.19% of the total trading value.
Minsheng Health’s 2025 Q3 report shows that, for the first three quarters, the company’s main operating revenue was 623 million yuan, up 19.78% year over year; net profit attributable to the parent was 114 million yuan, up 32.77% year over year; non-recurring profit net profit was 87.9699 million yuan, up 6.79% year over year. Of this, in 2025 third quarter alone, the company’s main operating revenue was 160 million yuan, up 30.84% year over year; net profit attributable to the parent for the quarter was 32.0114 million yuan, up 259.31% year over year; non-recurring profit net profit for the quarter was 86.412 million yuan, up 10.53% year over year. The asset-liability ratio was 14.92%, investment income was 9.5821 million yuan, and financial expenses were -7.0184 million yuan. Gross margin was 52.09%. Minsheng Health (301507) main business: R&D, production, and sales of over-the-counter drugs and health foods in the vitamins and minerals category.
Explanation of capital flow terms: It refers to the capital flow direction inferred from price changes. When the stock price is in an upward trend, the trading value formed by proactive buy orders is the force driving the stock price higher; this portion of trading value is defined as capital inflow. When the stock price is in a downward trend, the trading value produced by proactive sell orders is the force driving the stock price lower; this portion of trading value is defined as capital outflow. The difference between the two on the day is the net force remaining after the two forces offset each other, pushing the stock price up. Capital flow direction for institutional main funds, brokerage funds, and retail funds is calculated based on trade-by-trade transaction amounts.
Note: “Institutional main funds” are trades of very large orders; “brokerage funds” are trades of large orders; “retail investors” are trades of small and medium orders.
The above content has been compiled by Securities Star from publicly available information and generated by an AI algorithm (Network information filing record 310104345710301240019). It does not constitute investment advice.